PEG-3350 AND ELECTROLYTES: payments to doctors
Payments that named PEG-3350 AND ELECTROLYTES as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.2M
- Providers
- 2
- Transactions
- 70
- Average per transaction
- $45,662
The per-transaction average — $45,662 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2 providers the average total is $1,598,157, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Affordable Pharmaceuticals, LLC | $2,796,522 | 87.5% |
| Braintree Laboratories, Inc. | $399,793 | 12.5% |